期刊文献+

MDM2与MMP-9在骨肉瘤组织中的表达及临床意义 被引量:2

Expressions of MDM2 and MMP - 9 in osteosarcoma tissue and clinical significances
下载PDF
导出
摘要 目的探讨骨肉瘤中MDM2、MMP-9的表达与骨肉瘤病理特征、转移及预后的关系。方法采用免疫组织化学(S—P)法检测61例骨肉瘤标本中MDM2、MMP-9的表达情况,并分析MDM2、MMP-9的表达与骨肉瘤病理特征、转移及预后的关联性。同时设20例正常骨组织为阴性对照组。结果MDM2、MMP-9在骨肉瘤组织中的阳性表达率均高于正常骨组织(P〈0.001),其表达与性别、年龄及病理分级无关(P〉0.05),与骨肉瘤的转移和预后相关(P〈0.05),且二者表达呈正相关(P〈0.05)。二者同时阳性表达与骨肉瘤转移有高度关联性,其生存率明显低于同时阴性表达者,有显著性差异(P〈0.001)。结论MDM2、MMP-9表达异常的骨肉瘤组织恶性程度高、预后差。MDM2、MMP-9蛋白表达的改变可能与骨肉瘤发生发展相关,检测骨肉瘤中MDM2和MMP-9的表达水平对其预后评估有重要意义。 Objective To explore the relationship of the expressions of MDM2 and MMP - 9 in osteosarcoma with the pathological parameters and prognosis of the tumor. Methods The expressions of MDM2 and MMP -9 were detected with immunohistochemieal (S - P)method in specimens from 61 cases of osteosarcoma. The correlation between the expressions of MDM2, MMP - 9 and pathological characteristic, metastasis and prognosis was analyzed statistically. While 20 cases of normal osseous tissue were used as negative control group. Results The positive rates of MDM2 and MMP - 9 in osteosarcoma were higher than those in the normal osseous tissue respectively(P 〈0.001 ). The expression of MDM2 and MMP -9 were not correlated to the sex,age and pathological grades of the osteosarcoma( P 〉 0.05 ), but correlated to tumor metastasis and prognosis( P 〈 0.05 ). The five - year survial rate in patients with positive expression of MDM2 and/or positive expression of MMP - 9 was significantly lower than that in negative control group ( P 〈 0. 001 ). The patients with positive reaction for both MDM2 and MMP- 9 had the lowest survival rate, the difference was signifieant( P 〈 0.001 ). Conclusion There is an intimate correlation between the overexpression of MDM2 and MMP - 9 in osteosarcoma and it is useful parameter to evaluate prognosis of osteosareoma.
作者 黄岩 王俊萍
出处 《实用肿瘤学杂志》 CAS 2009年第1期35-37,47,共4页 Practical Oncology Journal
关键词 骨肉瘤 MDM2 MMP-9 免疫组织化学 Osteosareoma MDM2 MMP - 9 Immunohistochemistry
  • 相关文献

参考文献9

  • 1Park HR, Jung WW, Bertoni F, et al. Molecular analysis of p53, MDM2 and H -ras genes in low -grade central osteosarcoma[J]. Pathol Res Pract,2004,200(6) :439 -445.
  • 2Uchibori M, Nishida Y, Nagasaka T,et al. Increased expression of membrane - type matrix metalloproteinase - Ⅰ is correlated with poor prognosis in patients with osteosarcoma [J]. Int J Oncol,2006,28( 1 ) :33 -42.
  • 3Charity RM, Foukas AF, Deshmukh NS, et al. Vascular endothelial growth factor expression in osteosarcoma [ J]. Clin Orthop Relat Res ,2006,448 : 193 - 198.
  • 4Tsunemi T, Nagoya S, Kaya M, et al. Postopreative progression of pulmonary metastasis in osteosarcoma [ J ]. Clin Orthop Relat Res ,2003,407 : 159 - 166.
  • 5Lahav G, Rosenfeld N, Sigal A, et al. Dynamics of the p53/ MDM2 feedback loop in individual cells [ J ]. Nat Genet, 2004,36(2) :147 - 150.
  • 6Ganguli G, Wasylyk B. p53 - independent functions of MDM2 [ J ]. Mol Cancer Res,2003,1 (14) : 1027 - 1035.
  • 7Ohta M, Konno H,Tanaka T, et al. The significance of circulating vascular endothelial growth factor ( VEGF ) protein in gastric cancer [ J ]. Cancer Lett ,2003,192 (2) :215 - 225.
  • 8Cho JH,Kim HS,Park CS,et al. Maspin expression in early oral tongue cancer and its relation to expression of mutant - type p53 and vascular endothelial growth factor (VEGF) [ J ]. Oral Oncol,2007,43 (3) :272 - 277.
  • 9Uchibori M,Nishida Y,Nagasaka T,et al. Increased expression of membrane - type matrix metalloproteinase - 1 is correlated with poor prognosis in patients with osteosarcoma [J]. Int J Oncol,2006,28( 1 ) :33 -42.

同被引文献28

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部